July 6, 2021
Visikol Partners with MatTek
It was announced today that Visikol will leverage the MatTek portfolio of advanced cell culture models within its drug discovery services.
News
June 23, 2021
EpiDerm™ approved by OECD as stand-alone in-vitro test method for phototoxicity
MatTek Life Sciences, a subsidiary of CELLINK, today announced the OECD acceptance of the EpiDerm Phototoxicity Test for Test Guideline 498.
March 10, 2021
MatTek Acquired By CELLINK
MatTek Corporation, a Boston-area life sciences company, announced today that it has been acquired by CELLINK.
October 27, 2020
MatTek Named a Massachusetts Manufacturer of the Year
The Massachusetts Legislature’s Manufacturing Caucus hosted its 5th Annual Manufacturing Award Ceremony virtually today.
October 21, 2020
EpiAirway and EpiDermFT Now Available from MatTek’s European Location
MatTek Life Sciences today announced the availability of its EpiAirway and EpiDermFT in vitro human tissues from its European location in Bratislava, Slovakia.
